DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis


Moore HB, Chapman MP, Hansen K. , et al.
Elevated fibrin degradation products with low fibrinolytic activity measured by thromboelastographic in severely injured patients does not warrant tranexamic acid to improve clot strength.
JACS 2019 (e-pub ahead of print)

Download Bibliographical Data

Search in: